Previous Article | Next Article 
Infect Immun. 1989 December; 57(12): 3743-3750
In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity.
D L Weinstein,
M P Jackson,
L P Perera,
R K Holmes and
A D O'Brien
Department of Microbiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799.
ABSTRACT
Shiga toxin, Shiga-like toxin I (SLT-I) and Shiga-like toxin II (SLT-II) are cell-associated cytotoxins that kill both Vero cells and HeLa cells, whereas Shiga-like toxin II variant (SLT-IIv) is an extracellular cytotoxin that is more cytotoxic for Vero cells than for HeLa cells. The basis for these differences in cytotoxin localization and host cell specificity were examined in this study. The A and B subunit genes of Shiga toxin and the SLTs were recombined by two methods so that hybrid toxins would be formed in vivo. Complementation of heterologous subunits was accomplished by cloning the individual A and B subunit genes of SLT-I, SLT-II, and SLT-IIv on plasmid vectors of different incompatibility groups so that they could be maintained in double transformants of Escherichia coli. In addition, six operon fusions were constructed so that the A and B subunit genes of Shiga toxin, SLT-II, and SLT-IIv could be expressed as a single operon. The activities of the hybrid cytotoxins were assessed in three ways: (i) level of cytotoxicity, (ii) ratio of HeLa to Vero cell cytotoxicity, and (iii) ratio of extracellular to cell-associated cytotoxicity. Neither the A subunit of Shiga toxin nor SLT-I associated with a heterologous B subunit to form an active cytotoxin. However, in all other cases the hybrid molecules formed by subunit complementation or operon fusion were cytotoxic. Furthermore, the cytotoxic specificity and localization of the hybrid cytotoxins always corresponded to the activities of the native toxin possessing the same B subunit.
Infect Immun. 1989 December; 57(12): 3743-3750
This article has been cited by other articles:
-
Serra-Moreno, R., Jofre, J., Muniesa, M.
(2008). The CI Repressors of Shiga Toxin-Converting Prophages Are Involved in Coinfection of Escherichia coli Strains, Which Causes a Down Regulation in the Production of Shiga Toxin 2. J. Bacteriol.
190: 4722-4735
[Abstract]
[Full Text]
-
Shimizu, T., Kawakami, S., Sato, T., Sasaki, T., Higashide, M., Hamabata, T., Ohta, T., Noda, M.
(2007). The Serine 31 Residue of the B Subunit of Shiga Toxin 2 Is Essential for Secretion in Enterohemorrhagic Escherichia coli. Infect. Immun.
75: 2189-2200
[Abstract]
[Full Text]
-
Wen, S. X., Teel, L. D., Judge, N. A., O'Brien, A. D.
(2006). A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2. Proc. Natl. Acad. Sci. USA
103: 7082-7087
[Abstract]
[Full Text]
-
Kovbasnjuk, O., Edidin, M., Donowitz, M.
(2002). Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells. J. Cell Sci.
114: 4025-4031
[Abstract]
[Full Text]
-
Soltyk, A. M., MacKenzie, C. R., Wolski, V. M., Hirama, T., Kitov, P. I., Bundle, D. R., Brunton, J. L.
(2002). A Mutational Analysis of the Globotriaosylceramide-binding Sites of Verotoxin VT1. J. Biol. Chem.
277: 5351-5359
[Abstract]
[Full Text]
-
Konadu, E., Donohue-Rolfe, A., Calderwood, S. B., Pozsgay, V., Shiloach, J., Robbins, J. B., Szu, S. C.
(1999). Syntheses and Immunologic Properties of Escherichia coli O157 O-Specific Polysaccharide and Shiga Toxin 1 B Subunit Conjugates in Mice. Infect. Immun.
67: 6191-6193
[Abstract]
[Full Text]
-
Kudva, I. T., Blanch, K., Hovde, C. J.
(1998). Analysis of Escherichia coli O157:H7 Survival in Ovine or Bovine Manure and Manure Slurry. Appl. Environ. Microbiol.
64: 3166-3174
[Abstract]
[Full Text]
-
Paton, J. C., Paton, A. W.
(1998). Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections. Clin. Microbiol. Rev.
11: 450-479
[Abstract]
[Full Text]
Copyright © 1989 by the American Society for Microbiology. All rights reserved.